|
|
Treating CKD in Type 2 Diabetes: Combination Therapy is Key
|
|
Facebook
LinkedIn
E-Mail
|
(2500)
Other: Assessment, Cardiometabolic, Diabetes Mellitus, Diagnosis, Diagnostic Tests, Evaluation (Follow-up), Evidence-Based Guidelines, Kidney, Laboratory Interpretation, Pharmacology, Planning, Prevention, Primary Care, Renal, Screening, Treatment, Treatment Plan
(show less)
|
Released: 04/25/2024
Expires: 04/30/2025 (subject to change)
- CE for this activity will not be available after this date.
Overview
Type 2 diabetes (T2D) is a major cause of chronic kidney disease (CKD) in the United States. Up to 40% of people living with T2D will develop CKD. In this two-part program, NP experts Drs. Kathryn Kreider and Timothy Ray will provide an overview of guideline-recommended treatments with you and help you overcome clinical inertia in the management of your patients with CKD and T2D. In the second part of the program you will have an opportunity to put your knowledge into practice by interacting with engaging case studies.
Objectives - Summarize the pathophysiologic changes underlying the development and progression of chronic kidney disease (CKD) in patients with type 2 diabetes (T2D).
- Devise a plan to overcome clinical inertia in the diagnosis, monitoring, and ongoing management of CKD in patients with T2D.
- Discuss the treatment benefits of guideline-recommended SGLT2 inhibitors, RAAS inhibitors, and nonsteroidal mineralocorticoid receptor antagonists for people with T2D and CKD.
Speakers
Kathryn Evans Kreider, DNP, APRN, FNP-BC, BC-ADM, FAANP
Timothy Ray, DNP, CNP, CNN-NP
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.The speakers have the following disclosures: - Kathryn Kreider has no relevant financial relationships to disclose.
- Tim Ray has no relevant financial relationships to disclose.
All Planners involved in this activity have no relevant financial relationships to disclose. This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
Disclaimer
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions- Read this activity description, including objectives and disclosures.
- Complete the educational content:
- Access the first part of the activity labeled "Video Activity."
- Complete the pre-test.
- Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
- Complete the post-test.
- Access the second part of the activity labeled "Case Studies"
- Click the Play button to launch the interactive activity. Full participation credit for the activity will be received once the end of the activity has been reached.
- Access additional downloadable content by clicking on the Additional Resources button (handouts, post-test reviews, any other downloadable resources).
- After completing both the video and case study content, return to the parent-module and click on the blue Next Steps button:
- Submit the evaluation to receive full AANP CE/Rx credit.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
1.5 Contact Hour(s) of CE,
0.5 of which may be applied towards Pharmacology
|
|
|
|
Adding Registration, Please wait...
